Dr. Frank Sammarco, M.D

NPI: 1407953920
Total Payments
$1,567
2024 Payments
$646.62
Companies
15
Transactions
46
Medicare Patients
3,228
Medicare Billing
$334,728

Payment Breakdown by Category

Food & Beverage$1,551 (99.0%)
Education$16.14 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,551 45 99.0%
Education $16.14 1 1.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Biotech, Inc. $266.56 14 $0 (2024)
Novartis Pharmaceuticals Corporation $225.14 2 $0 (2018)
Takeda Pharmaceuticals U.S.A., Inc. $192.03 10 $0 (2024)
Ardelyx, Inc. $174.48 8 $0 (2024)
DePuy Synthes Sales Inc. $125.03 1 $0 (2017)
Ethicon US, LLC $116.81 1 $0 (2018)
Merck Sharp & Dohme Corporation $101.87 1 $0 (2017)
GlaxoSmithKline, LLC. $101.71 1 $0 (2018)
Allergan Inc. $80.60 1 $0 (2018)
PFIZER INC. $51.69 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $646.62 32 Janssen Biotech, Inc. ($241.88)
2023 $81.40 4 Takeda Pharmaceuticals U.S.A., Inc. ($39.87)
2022 $16.14 1 E.R. Squibb & Sons, L.L.C. ($16.14)
2021 $19.86 1 Boston Scientific Corporation ($19.86)
2018 $399.26 4 Ethicon US, LLC ($116.81)
2017 $403.59 4 DePuy Synthes Sales Inc. ($125.03)

All Payment Transactions

46 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/19/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $22.38 General
Category: GASTROENTEROLOGY
12/16/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $19.00 General
Category: Immunology
12/02/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $23.39 General
Category: INTERNAL MEDICINE
11/11/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $21.72 General
Category: GASTROENTEROLOGY
11/04/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $22.03 General
Category: Immunology
10/28/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $20.51 General
Category: INTERNAL MEDICINE
10/28/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $1.00 General
Category: INTERNAL MEDICINE
10/21/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $26.03 General
Category: GASTROENTEROLOGY
10/14/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $27.60 General
Category: IMMUNOLOGY
10/07/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $20.18 General
Category: Immunology
09/20/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $21.86 General
Category: Immunology
09/16/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $21.51 General
Category: INTERNAL MEDICINE
08/28/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $12.85 General
Category: GASTROENTEROLOGY
08/26/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $24.45 General
Category: Immunology
08/19/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $24.42 General
Category: INTERNAL MEDICINE
07/22/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $27.58 General
Category: GASTROENTEROLOGY
07/10/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $27.82 General
Category: Immunology
06/17/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $20.99 General
Category: Immunology
06/10/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $14.82 General
Category: Immunology
06/03/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $24.55 General
Category: GASTROENTEROLOGY
05/13/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $21.37 General
Category: INTERNAL MEDICINE
05/06/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $24.96 General
Category: GASTROENTEROLOGY
04/29/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $20.69 General
Category: Immunology
04/15/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $20.37 General
Category: Immunology
04/12/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $14.41 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 798 833 $460,595 $85,176
2022 11 784 878 $431,380 $86,335
2021 13 860 948 $494,225 $94,041
2020 18 786 869 $335,884 $69,176
Total Patients
3,228
Total Services
3,528
Medicare Billing
$334,728
Procedure Codes
53

All Medicare Procedures & Services

53 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 156 159 $150,905 $18,922 12.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 186 214 $46,270 $14,815 32.0%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 61 61 $72,980 $13,330 18.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 127 129 $85,240 $9,883 11.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 115 115 $30,685 $8,461 27.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 55 55 $21,795 $6,513 29.9%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 19 19 $11,925 $3,565 29.9%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 21 22 $19,520 $3,160 16.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 27 28 $8,580 $3,042 35.5%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 16 16 $10,050 $2,800 27.9%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 15 15 $2,645 $684.61 25.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 215 300 $63,755 $21,193 33.2%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 113 115 $112,365 $14,568 13.0%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 51 52 $62,980 $10,895 17.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 110 111 $76,155 $9,150 12.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 96 96 $27,420 $7,659 27.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 49 49 $21,305 $6,263 29.4%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 23 23 $16,630 $4,454 26.8%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 17 18 $12,685 $3,269 25.8%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2022 63 63 $12,425 $3,113 25.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 30 30 $9,235 $2,975 32.2%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 17 21 $16,425 $2,796 17.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 179 234 $49,140 $17,678 36.0%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 71 72 $89,280 $15,917 17.8%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 134 139 $102,860 $11,194 10.9%

About Dr. Frank Sammarco, M.D

Dr. Frank Sammarco, M.D is a Gastroenterology healthcare provider based in Norwalk, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407953920.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Sammarco, M.D has received a total of $1,567 in payments from pharmaceutical and medical device companies, with $646.62 received in 2024. These payments were reported across 46 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,551).

As a Medicare-enrolled provider, Sammarco has provided services to 3,228 Medicare beneficiaries, totaling 3,528 services with total Medicare billing of $334,728. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Norwalk, CT
  • Active Since 09/19/2006
  • Last Updated 12/16/2011
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1407953920

Products in Payments

  • ENTRESTO (Drug) $225.14
  • ENTYVIO (Biological) $192.03
  • IBSRELA (Drug) $174.48
  • TREMFYA (Drug) $153.73
  • VIPER (Device) $125.03
  • LINX Reflux Management System (Device) $116.81
  • JANUVIA (Drug) $101.87
  • SHINGRIX (Biological) $101.71
  • STELARA (Biological) $88.15
  • LINZESS (Drug) $80.60
  • ELIQUIS (Drug) $51.69
  • HYLENEX RECOMBINANT (Biological) $31.20
  • RINVOQ (Biological) $27.60
  • REMICADE (Biological) $24.68
  • GENERAL GI DILATATION (Device) $19.86
  • Omidria (Drug) $19.30
  • ZEPOSIA (Drug) $16.14

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Norwalk